Sept. 29th Life Science Angels Mentoring Sessions_applicants
Comments
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

 
$
%
123
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Still loading...
ABCDEFGHIJKLMNOPQRSTUVWX
1
Life Science Angels Mentoring Sessions (UCSF MISSION HALL)
2
SIGN UP HERE IF YOU HAVE A UCSF AFFILIATION, CURRENT OR ALUM (use UCSF email address if available)
3
Venture NameVenture Lead's NameLead's titleEmail:Phone2-Sentence DescriptionSector (Tx,Dx, etc)::::33)3343
4
OoneyEmily FinlaysonCo-founderemily.finlayson@ucsf.edu415-476-5147PrehabPal is a hybrid app-website that prepares older adults for surgeryDigital Health/Health ITUCSF faculty
5
Nextrast, IncBenjamin YehFounderben.yeh@ucsf.edu415-680-5204We are developing novel oral contrast material licensed from UCSF to allow modern dual energy CT to differentiate between simultaneously delivered contrast agents and give high resolution images of intertwined anatomy in the abdomen. Founders are UCSF faculty.Diagnostics, Drug, Combination productUCSF faculty
6
LampreySam SeymourCo-foundersam.seymour@berkeley.edu (preferred); sam.seymour@ucsf.edu781-775-3332Traditional tools used for grasping tissues during laparoscopic surgery can cause injuries that lead to poor outcomes and higher costs for payers and hospitals. The Lamprey is a novel, vacuum-based tool that will reduce injury and aims to replace the standard of care.Surgical devices
7
FustibalDavid TranFounderdavid@fustibal.com415-669-4421Fustibal develops targeted therapeutics and companion diagnostics through data-based computational platforms. We refine target-specificity and broaden therapeutic use of existing pharmaceuticals.Therapeutics and DiagnosticsUCSF alum
8
712 North IncMarcel AlaviFoundermarcel.alavi@gmail.com415 489 8995Nobody wants to get blind. 712 North Inc. develops neuroprotective therapies for glaucoma, the leading cause of incurable blindness. We have identified a novel target for the orphan childhood disease dominant optic atrophy that shares the mechanism-of-action with glaucoma and we develop small molecule therapies for both diseases.TherapeuticsUCSF alum/ Startup 101
9
Tradewind BioScienceThaddeus AllenFounderthaddeusallen01@gmail.com415-317-4818Tradewind has discovered an "on/off" switch for metastasis. We are building a novel therapeutic and a companion diagnostic based on this novel oncotarget.Therapeutics and DiagnosticsUCSF alum
10
Kidney MetrixMichael FernandezFoundermichael@quant6.com415.377.5761Diagnostic test and service designed to detect early stage kidney disease and monitor kidney health. We help physicians monitor kidney health during chronic disease treatments and improve care using our Laboratory Developed Tests and Clinically Actionable Reports preprared by our nephrologists. DiagnosticsUCSF Startup 101
11
Blu Lotus HealthCalvin MoreeCo-foundercalvin@blulot.us650-667-8000The LeanCase(TM) information visualization system enables teams and departments to self-coordinate thereby improving workflow and handoffs resulting in improved patient experiences, OR efficiency and patient safety throughout the perioperative suite.Digital Health/Health ITUCSF Lean Launchpad & Employee
12
Phi TherapeuticsYug VarmaCEOyug@phitherapeutics.com443-827-8060We are developing microbiome therapeutics to treat bacterial skin diseases, starting with acne. Using proprietary bacteriophage and probiotic bacteria we are recalibrating the microbiome to a healthy state.TherapeuticsUCSF alum
13
PillButlerKristin McCulloughFounderkristin@pillbutler.org408-656-6555Medication Management HealthtechUCSF faculty - Dr Stan Schiffer
14
Alaunus BiosciencesFrancesco CaiazzaScientist 1francesco.caiazza@ucsf.edu415-849-5928Alaunus Biosciences is a preclinical-stage oncology company addressing unmet clinical needs in cancer diagnosis and treatment. We take advantage of the unique protease activity signature present in the tumor microenvironment, and leverage it to develop protease- activated cancer therapeutics and protease-based diagnostic biomarkers.Therapeutics/DiagnosticsUCSF faculty - Charles Craik
15
NeurogenicsMarcel AlaviCSOmarcel.alavi@gmail.com415 489 8995Neurogenics develops, designs and produces a unique objective non-invasive biomarker for early identification, characterization, and assessment of the efficacy of therapies for neurodegenerative diseases currently afflicting over 1 billion people worldwide. The technology involves an integration of optical coherence tomography (OCT) and adaptive optics (AO) to take granular images of mitochondria dysfunction within retinal ganglion cells and a proprietary algorithm to convert these images into precise diagnoses for a range of neurodegenerative diseases, beginning with Alzheimer’s, glaucoma, and Parkinson’s.DiagnosticsUCSF alum - UCLA faculty Alfredo Sadun - Stanford faculty Jeff Goldberg
16
Zeus Photobiotics Leon ChungCo-founderleon.chung@ucsf.edu510-861-8837Zeus Photobiotics is a medical device company that is focused on using light therapy to treat diseases. We are developing a laser that can be use as an alternative treatment to amputation. Medical Devices UCSF Lean Launchpad
17
BioTalonJenny LiuCo-founderjennyliu@alum.mit.edu(650) 787-1566Therapeutic agents are fraught with high systemic toxicities from non-specific or off-target binding that limit cancer patients to active therapy for short periods before they stop to physically recover. By utilizing unique physical properties of cancer cells, BioTalon is creating a new class of therapeutic antibodies that bind specifically to their targets by leveraging the exquisite specificity that antibodies bring to therapeutics.Tx and DxUCSF Lean LaunchPad
18
19
20
21
SIGN UP BELOW IF YOU DO NOT HAVE A UCSF AFFILIATION
22
Venture NameVenture Lead's NameLead's titleEmailPhone2-Sentence DescriptionSector (Tx,Dx, etc)Affiliation
23
Smart FocusMichael YoungCEOmike@smartfocusvision.com415-390-6668Smart Focus is a high-growth eye care company spun-out of Stanford. It is ​backed by the world's leading eye care, financial, and research institutions.Eye care
24
Apollo MedsystemsBrian NeilFounderbrian.neil@gmail.com3145181267Apollo is focused on making care in the NICU better. We're building wireless leads that will allow babies to be cared for and handled much more easilyDiagnositcs
25
SalusiveWaleed MohsenFounderwaleed@salusive.com949.922.9562Salusive is a mobile health platform that helps providers treat patients with chronic conditions by tracking vitals remotely and meeting over video. The data collected can be analyzed to make meaningful predictions of disease so providers have an opportunity to intervene. Digital Health/telemedicine
26
Nodexus Inc.Karthik BalakrishnanCEOkarthik@nodexus.com573-263-1345Nodexus is an Angel-, Venture-, and SBIR-funded company that is developing a hardware platform and single-use disposable cartridges to provide access to precious samples (e.g. single biological cells) of interest for applications in gene editing (e.g. CRISPR engineering), tumor heterogeneity (including liquid biopsy), high-throughput drug discovery and targeting, and more. Following extensive market validation from key opinion leaders and pilot collaborators, we have identified pain points in accessing precious biological samples at a single-cell level within the financial, workflow, and sample limitations facing researchers; our NX-One system can address all of these unmet needs.Research Tool
27
AptaScan Inc.Tim SauderCEOtimsauder@aptascan.com740-341-3491We’re building a handheld consumer device that non-invasively measures and quantitates hormone biomarkers levels. While our device can monitor a broad array of biomarkers we've found that women's health, specifically ovulation monitoring, to be by far the best product/market fit.Diagnositcs
28
Hippo Diagnostics Inc.Violet VotinCEOvvotin@gmail.com650-387-1379To address the rampant misdiagnosis of ear infection and billions of dollars in over-treatment -- including antibiotic overuse, we are developing non-invasive in vitro diagnostics that let parents distinguish which ear infections will benefit from antibiotics.Diagnosticsalum of UCSF Lean Launchpad
29
Defiant Airway ManagmentTrevor WesolowskiFounderdefiantam@gmail.com703 472 5126Our device provides fastand safe ventilation for general anesthesia patients. From induction to extubation we reduce the risk of injury and breathing obstructions for patients while enhancing physician's visual and manual access to critical patient airways. Devicesalum of UCSF Lean Launchpad
30
TAXA BiotechnologiesAntony EvansFounderantony@taxa.com415.779.6333Genetic engineering of plants for the homeSynthetic biology
31
Clinical PersonaLjubomir ButurovicCEOljubomir@clinicalpersona.com408.506.1290Developing machine learning algorithms which diagnose disease or predict outcomes using genomic and clinical data. Our mission is helping realize the promise of precision medicine by matching treatments to patients' genome and clinical history.Big Data Precision Medicine
32
Pathos TechnologiesBlair DoreCEOblair@pathosim.com650.471.9499Developing a simulation designed for helping people diagnose and treat mental illness. The platform allows lifelike interviews with virtual patients portrayed by actors, and is able to asses user performance and efficacy.Medical Education Technologypiloted the simulation at UCSF with Dr. Eric Hung this summer.
33
Caseforge, Inc. Young ParkFounderyoung@caseforge.co415-570-3506We create personalized cases to eliminate motion and guarantee repeat positioning for MRIs and radiotherapy. We do this using a portable 3D scanner, computational geometric algorithms, proprietary CAM software, and Caseforge CNC mills to provide precise fitted cases with rapid turnaround times. Medical devicesUC Berkeley
34
Elemeno HealthArup Roy-BurmanCEOarup.roy-burman@ucsf.edu510.220.1595We are a best practices management and delivery platform for healthcare organizations. We drive frontline staff engagement and deliver the right practice to the right patient at the right time.Digital HealthUCSF
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
×
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
Loading...
 
 
 
Sheet1